Clinical Trial Update: Treatment of Wegener's Granulomatosis With Cyclophosphamide [Phase 2]

View source ↗

Summary

Phase 2 trial examining cyclophosphamide for vasculitis due to granulomatosis with polyangiitis (Wegener's granulomatosis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Vasculitis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Vasculitis, Wegener's Granulomatosis | Phase 2 | Status: COMPLETED